Search

everythinglearnresearchcommunity

for

Search:↓

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Certain drugs that block specific enzymes can help treat prostate diseases.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

New hybrid compound found to effectively prevent hair loss.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.